ClinicalTrials.Veeva

Menu

Effect of General Anesthesia on Enterocyte Damage (GUT)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

General Anesthesia
Non-urgent Surgery

Study type

Observational

Funder types

Other

Identifiers

NCT02199275
P/2013/174

Details and patient eligibility

About

During non urgent surgery, general anesthesia might induce enterocyte damage. I-FABP is a performant biomarker of enterocyte damage. We aimed to study whether patient ongoing general anesthesia for non-urgent surgery have an elevation of plasma I-FABP concentration.

Full description

Inclusion criteria

  • Indication of non-urgent surgery
  • General anesthesia protocol using propofol and remifentanyl
  • One half of the patients have a history of ischemic arteriopathy
  • One half of the patients have no history of ischemic arteriopathy

Exclusion criteria

  • Age < 18 years old
  • Pregnant

Primary objective

Is there a significant elevation of I-FABP between the pre-anesthesic period and 11 minutes after induction of general anesthesia ?

Secondary objectives

  1. Is I-FABP elevation higher among patients with history of patent arteriopathy ?
  2. Is I-FABP elevation higher among patients presenting with hypotension during anesthesia ?

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Indication of non-urgent surgery
  • General anesthesia protocol using propofol and remifentanyl
  • One half of the patients have a history of ischemic arteriopathy
  • One half of the patients have no history of ischemic arteriopathy

Exclusion criteria

  • Age < 18 years old
  • Pregnant

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems